首页> 外文期刊>National Journal of Medical Research >A STUDY OF METALLO-BETA-LACTATAMASE PRODUCING PSEUDOMONAS AERUGINOSA IN CLINICAL SAMPLES OF S.S.G. HOSPITAL
【24h】

A STUDY OF METALLO-BETA-LACTATAMASE PRODUCING PSEUDOMONAS AERUGINOSA IN CLINICAL SAMPLES OF S.S.G. HOSPITAL

机译:金黄色葡萄球菌-乳糖苷酶在铜绿假单胞菌临床样品中产生铜绿假单胞菌的研究医院

获取原文
           

摘要

Introduction: Pseudomonas spp. is common pathogen causing nosocomial infection. Acquired drug resistance is frequent in nosocomial isolates of Pseudomonas spp. Acquired metallo-?2-lactamases (MBL) in pseudomonas spp. have recently emerged as one of the most worrisome resistance mechanism because of their capacity to hydrolyze all beta-lactam antibiotics including penicillins, cephalosporins and carbapenems, with the exception of aztreonam. Aim: To detect metallo-?2-lactamase producing isolates of Pseudomonas aerugenosa from various clinical samples from patients admitted in our hospital. Material and methods : In this studyt we studied the prevalence, following standard methods of isolation and identification techniques of these bacteria from clinical materials Source : Samples of patients from different wards of S.S.G.Hosital are proceeded in Microbiology department , Medical College and S.S.G.Hospital Baroda. Results: Of total study of 150 isolates of Pseudomonas aeruginosa, 8 isolates are resistance to Imipenem . Of 8 samples , all are producing Metallo-Beta-Lactamase enzyme. Conclusion :Infection cause by MBL (metallo-?2-lactamase) positive isolates of Pseudomonas aerugenosa is important to identify because it poses not only therapeutic problem, but also a serious concern for infection control management.
机译:简介:假单胞菌属。是引起医院感染的常见病原体。获得性耐药性在假单胞菌属的医院分离株中很常见。获得的假单胞菌属金属-β2-内酰胺酶(MBL)。由于其能水解包括青霉素,头孢菌素和碳青霉烯在内的所有β-内酰胺抗生素的能力,最近已成为最令人担忧的耐药机制之一,氨曲南除外。目的:从我院收治的患者的各种临床样本中检测铜绿假单胞菌产生金属-β2-内酰胺酶的分离株。材料和方法:在本研究中,我们按照标准方法从临床材料中分离和鉴定这些细菌的患病率进行了研究。资料来源:来自S.S.G.医院不同病房的患者的样本是在医学院微生物学系和S.S.G.医院Baroda进行的。结果:在150株铜绿假单胞菌的总研究中,有8株对亚胺培南具有抗药性。在8个样本中,所有样本均产生Metallo-β-内酰胺酶。结论:铜绿假单胞菌MBL(金属-β2-内酰胺酶)阳性分离株引起的感染很重要,因为它不仅引起治疗问题,而且也引起感染控制管理的严重关注。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号